期刊文献+

飞行时间质谱技术在结直肠癌K—ras基因突变检测中的应用 被引量:3

Application of matrix assisted laser desorption ionization-time of flight-mass spectrometry in detecting K-ras gene mutation of colorectal cancer
原文传递
导出
摘要 目的探讨MALDI—TOF—MS方法在检测结直肠癌K—ras基因突变中的实际临床价值。方法选取61例结直肠癌患者的肿瘤组织石蜡标本.应用常规测序和基质辅助激光解析/电离时间飞行质谱(MALDI-TOF-MS)两种方法.检测K-ras基因第2号外显子中第12及13位密码子的前两位碱基突变情况。结果常规测序法成功完成检测47例(77.0%),而MALDI-TOF-MS法成功检测所有61例标本。常规测序法检测样本总体突变率为30.0%(14/47),MALDI-TOF-MS法检测所有标本的总体突变率为36.1%(22/61)。6例样本常规测序法未检测到突变而质谱法检测到明确突变存在。14例样本经两种方法均检测出突变.且两种方法检测出的突变类型完全一致。2例样本未完成常规测序检测而通过质谱法检测出突变。结论相对常规测序而言,MALDI-TOF-MS法是一种对标本质量要求较低、更敏感的结直肠癌K-ras突变检测方法,有更好地临床价值。 Objective To investigate the clinical value of matrix assisted laser desorption ionization-time of flight-mass spectrometry (MALDI-TOF-MS) in detecting K-ras gene mutation. Methods Sixty-one paraffin-embeded specimens of colorectal cancer were selected. MALDI-TOF-MS and regular sequencing were used to test the mutation of codon 12 and 13 in K-ras exon 2. Results Only 47 specimens could be detected successfully in regular sequencing, while all the specimens were tested successfully in MALDI-TOF-MS. Fourteen specimens had K-ras mutation in regular sequencing (30.0%), while 22 specimens had mutation in MALDI-TOF-MS (36.1%). Six specimens with mutation were found in MALDI-TOF-MS but were wild-type in regular sequencing. Same mutation types from 14 specimens were confirmed by both regular sequencing and MALDI-TOF-MS. MALDI-TOF-MS was able to detect the mutation in 2 specimens that was not identified in regular sequencing. Conclusions MALDI-TOF-MS is a feasible approach of K-ras gene mutation testing in colorectal cancer, which is less demanding in terms of specimen quality and is more sensitive as compared to regular sequencing.
出处 《中华胃肠外科杂志》 CAS CSCD 2013年第1期80-83,共4页 Chinese Journal of Gastrointestinal Surgery
关键词 结直肠肿瘤 基因 K-ras 基因突变 基质辅助激光解析 电离时间飞行质谱 Colorectal neoplasms Gene, K-ras Gene mutation Matrix assisted laserdesorption ionization-time of flight-mass spectrometry
  • 相关文献

参考文献14

  • 1Cunningham D,Humblet Y,Siena S. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecanrefractory metastatic colorectal cancer[J].New England Journal of Medicine,2004.337-345.
  • 2Lièvre A,Bachet JB,Boige V. KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab[J].Journal of Clinical Oncology,2008,(3):374-379.doi:10.1200/JCO.2007.12.5906.
  • 3Karapetis CS,Khambata-Ford S,Jonker D J. K-ras mutations and benefit from cetuximab in advanced colorectal cancer[J].New England Journal of Medicine,2008.1757-1765.
  • 4Ma ES,Wong CL,Law FB. Detection of KRAS mutations in colorectal cancer by high-resolution melting analysis[J].Journal of Clinical Pathology,2009.886-891.
  • 5Angnlo B,Garcia-Garcia E,Martinez R. A commercial real-time PCR kit provides greater sensitivity than direct sequencing to detect KRAS mutations:a morphology-based approach in colorectal carcinoma[J].Journal of Molecular Diagnostics,2010.292-299.
  • 6Bradi(c) M,Costa J,Chelo IM. Genotyping with Sequenom[J].Methods in Molecular Biology,2011.193-210.
  • 7Yi X,Li J,Yu S. A new PCR-based mass spectrometry system for high-risk HPV,part I methods[J].American Journal of Clinical Pathology,2011.913-919.
  • 8Arcila M,Lau C,Nafa K. Detection of KRAS and BRAF mutations in colorectal carcinoma:roles for highsensitivity locked nucleic acid-PCR sequencing and broadspectrum mass spectrometry genotyping[J].Journal of Molecular Diagnostics,2011.64-73.
  • 9Ehrich M,Deciu C,Zwiefelhofer T. Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood:a study in a clinical setting[J].American Journal of Obstetrics and Gynecology,2011.205e1-20e11.
  • 10Sascha S. Typing of single nucleotide polymorphisms by MALDI mass spectrometry:principles and diagnostic applications[J].Clinica Chimica Acta,2006.95-105.

二级参考文献14

  • 1Lengauer C, Ennech WK, Vogelstein B. Genetic instabilities in human cancers[J]. Nature, 1998, 396(17): 643-649.
  • 2Gertig DM, Hunte DJ. Genes and environment in the etiology of colorectal cancer[J]. Cancer Biology, 1998, 8:285-298.
  • 3Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal tumor development [J].New England Medicine, 1988, 319: 525-532.
  • 4Kimura W, Zhao B, Futakawa N. Significance of K-ras codon 12 piont mutation in panereatic juice in the diagnosis of carcinoma of the pancreas [J]. Hepatogas-troenterology, 1999,46(25):532-539.
  • 5Claytonl SJ, Scott FM, Walker J, et al. Comparison of two approaches to somatic mutation detection using ARMS allele-specific amplification[J]. Clinical Chemistry,2000,46:1929-1938.
  • 6Donohoe GG, Laaksonen M, Pulkki K, et al. Rapid single-tube screening of the C282-Y hemochromatosis mutation by real-time multiplex allele-specific PCR without fluorescent probes[J]. Clin Chem,46(10): 1540-1547.
  • 7Hahner S, Kostrzewa M, Wenzel T, et al. Strategies for SNP genotypingby mass spectrometry [J]. International Congress Series, 2003,1239:11-16.
  • 8Bonka T, Humenya A, Sutterb C, et al. Molecular diagnosis of familial adenomatous polyposis (FAP): Genotyping of adenomatous polyposis coli (APC) alleles by MALDITOF mass spectrometry[J]. Clinical Biochemistry, 2002,35:87-92.
  • 9Griffin TJ, Smith LM. Single-nucleotide polymorphism analysis by MALDI-TOF mass spect-rometry[J]. Tibtech,2000,18:77 -84.
  • 10Schiebel K, Meder J, Rump A. Elevated DNA sequence diversity in the genomic region of the phosphatase PP2R3L gene in the human pseudoautosomal region [J].Cytogenet Cell Genet, 2000,91:224-230.

同被引文献8

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部